127
Views
9
CrossRef citations to date
0
Altmetric
Case Report

A case of developing progressive multifocal leukoencephalopathy while using rituximab and mycophenolate mofetil in refractory systemic lupus erythematosus

, , , &
Pages 1149-1153 | Published online: 26 Jun 2018

References

  • ChahinSBergerJRA risk classification for immunosuppressive treatment-associated progressive multifocal leukoencephalopathyJ Neurovirol201521662363125404234
  • TerrierBHummelAFakhouriFLeucoencéphalite multifocale progressive en dehors du sida : efficacité de l’association cytarabinecidfovir. [Progressive multifocal leukoencephalopathy in a non-AIDS patient: high efficiency of combined cytarabine and cidofovir]Rev Med Interne2007287488491 French17574710
  • EpperlaNMedina-FloresRMazzaJJYaleSHMirtazapine and mefloquine therapy for non-AIDS-related progressive multifocal leukoencephalopathyWMJ2014113624224525745699
  • BrickelmaierMLugovskoyAKartikeyanRIdentification and characterization of mefloquine efficacy against JC virus in vitroAntimicrob Agents Chemother20095351840184919258267
  • BeppuMKawamotoMNukuzumaSKoharaNMefloquine improved progressive multifocal leukoencephalopathy in a patient with systemic lupus erythematosusIntern Med201251101245124722687798
  • ElphickGFQuerbesWJordanJAThe human polyomavirus, JCV, uses serotonin receptors to infect cellsScience200430657001380138315550673
  • MolloyESCalabreseLHProgressive multifocal leukoencephalopathy associated with immunosuppressive therapy in rheumatic diseases: evolving role of biologic therapiesArthritis Rheum20126493043305122422012
  • MolloyESCalabreseLHProgressive multifocal leukoencephalopathy in patients with rheumatic diseases: are patients with systemic lupus erythematosus at particular risk?Autoimmun Rev20088214414618700172
  • AmendKLTurnbullBFoskettNIncidence of progressive multifocal leukoencephalopathy in patients without HIVNeurology201075151326133220938025
  • PalazzoEYahiaSAProgressive multifocal leukoencephalopathy in autoimmune diseasesJoint Bone Spine201279435135522281228
  • Galarza-MaldonadoCKourilovitchMRMolinerosJEThe administration of low doses of rituximab followed by hydroxychloroquine, prednisone and low doses of mycophenolate mofetil is an effective therapy in Latin American patients with active systemic lupus erythematosusAutoimmun Rev201010210811120804861
  • BasuBMahapatraTKMondalNMycophenolate mofetil following rituximab in children with steroid-resistant nephrotic syndromePediatrics20151361132139
  • HenegarCEEudyAMKharatVProgressive multifocal leukoencephalopathy in patients with systemic lupus erythematosus: a systematic literature reviewLupus201625661762626743322
  • MajorEOProgressive multifocal leukoencephalopathy in patients on immunomodulatory therapiesAnnu Rev Med201061354719719397
  • BellizziAAnzivinoERodioDMNew insights on human polyomavirus JC and pathogenesis of progressive multifocal leukoencephalopathyClin Dev Immunol2013201383971923690827
  • CliffordDNathACinquePA study of mefloquine treatment for progressive multifocal leukoencephalopathy: results and exploration of predictors of PML outcomesJ Neurovirol201319435135823733308
  • ElstonJWThakerHImmune reconstitution inflammatory syndromeInt J STD AIDS200920422122419304962
  • BossolascoSCaloriGMorettiFPrognostic significance of JC virus DNA levels in cerebrospinal fluid of patients with HIV-associated progressive multifocal leukoencephalopathyClin Infect Dis200540573874415714422
  • KeithRAGrangerCVHamiltonBBSherwinFSThe functional independence measure: a new tool for rehabilitationAdv Clin Rehabil198716183503663